Showing results (41-50 of 211) with videos related to
Sort By:
Pageof 22
International Journal of Technology Assessment in Health Care|August 23, 2005
Cost-effectiveness of drug-eluting coronary stents in Quebec, CanadaJames M Brophy, Lonny J EricksonInternational Journal of Cardiology|March 14, 2022
Pacemaker risk following transcatheter aortic valve replacement - A Bayesian reanalysisArthur M Albuquerque, James M BrophyAnnals of Internal Medicine|May 21, 2003
Evidence for use of coronary stents. A hierarchical bayesian meta-analysisJames M Brophy, Patrick Belisle, Lawrence JosephBMC Medicine|November 27, 2007
Validity of electron beam computed tomography for coronary artery disease: asystematic review and meta-analysisNandini Dendukuri, Keith Chiu, James M BrophyInternational Journal of Cardiology|April 24, 2016
Mortality risk of sotalol and amiodarone for post-CABG atrial fibrillationSarasa M A Johnson, James M BrophyNeurology|August 24, 2014
Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic studyMahyar Etminan, James M Brophy, Ali SamiiThe Canadian Journal of Cardiology|May 10, 2008
A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseasesZhi Song, Paul Brassard, James M BrophyPlos One|August 11, 2018
Studying additive interaction in a healthcare database: Case study of NSAIDs, cardiovascular profiles, and acute myocardial infarctionMichèle Bally, Lyne Nadeau, James M BrophyCirculation|May 30, 2007
Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survivalZeineb Hachicha, Jean G Dumesnil, Peter Bogaty, et al.Current Drug Safety|August 12, 2008
Use of statins and angiotensin converting enzyme inhibitors (ACE-Is) and the risk of age-related macular degeneration: nested case-control studyMahyar Etminan, James M Brophy, David MaberleyPageof 22